Milestone Pharmaceuticals (MIST) Cash from Operations (2018 - 2026)
Milestone Pharmaceuticals (MIST) posted Cash from Operations of 16053000.0 for Q1 2026, down 25.66% on a QoQ basis from 12775000.0 in Q4 2025, and down 15.06% year-over-year from 18898949.96 in Q1 2025.
Milestone Pharmaceuticals (MIST) Cash from Operations (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Cash from Operations history runs 9 years deep, the most recent figure standing at 16053000.0 for Q1 2026.
- Quarterly Cash from Operations fell 15.06% year-over-year to 16053000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 51142000.0 (down 51.01% YoY) and the FY2025 annual result came in at 49041000.0, down 70.0% from the prior year.
- Cash from Operations was 16053000.0 for Q1 2026 at Milestone Pharmaceuticals, down from 12775000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 6053000.0 in Q2 2024 and bottomed at 16053000.0 in Q1 2026.
- A 5-year average of 11343235.29 and a median of 12160000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations tumbled 1487.68% — and 2024, when it jumped 42.7%.
- Milestone Pharmaceuticals' Cash from Operations stood at 12862000.0 in 2022, then advanced by 23.84% to 9796000.0 in 2023, then jumped by 30.14% to 6843000.0 in 2024, then slumped by 86.69% to 12775000.0 in 2025, then slipped by 25.66% to 16053000.0 in 2026.
- Business Quant data shows MIST's Cash from Operations at 16053000.0 in Q1 2026, 12775000.0 in Q4 2025, and 9748000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | -16.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.05 Mn |
| Mar 31, 2026 | -16.05 Mn |
| Dec 31, 2025 | -12.78 Mn |
| Dec 31, 2025 | -12.78 Mn |
| Sep 30, 2025 | -9.75 Mn |
| Sep 30, 2025 | -9.75 Mn |
| Jun 30, 2025 | -12.57 Mn |
| Jun 30, 2025 | -12.57 Mn |
| Mar 31, 2025 | -13.95 Mn |
| Mar 31, 2025 | -13.95 Mn |
| Dec 31, 2024 | -6.84 Mn |
| Dec 31, 2024 | -6.84 Mn |
| Sep 30, 2024 | -7.02 Mn |
| Sep 30, 2024 | -7.02 Mn |
| Jun 30, 2024 | -6.05 Mn |
| Jun 30, 2024 | -6.05 Mn |
| Mar 31, 2024 | -8.93 Mn |
| Mar 31, 2024 | -8.93 Mn |
| Dec 31, 2023 | -9.80 Mn |
| Dec 31, 2023 | -9.80 Mn |